Skip to main content
OpenTrials

Clinical trial condition

Endometrial Neoplasms

Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.

999 public trials 299 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Neoplasms trial results

Recruiting

Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features

NCT05255653

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • The POLEmut-BLUE trial: Princess Margaret Cancer Centre, University of Toronto Toronto, Canada
  • The POLEmut-BLUE trial: University of British Columbia Vancouver, Canada
  • The p53abn-RED trial: Institute Gustave Roussy Villejuif, France
  • Amsterdam University Medical Center Amsterdam, Netherlands
View all 14 locations
View Trial Details
Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations
  • City of Hope Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
View all 85 locations
View Trial Details
Recruiting

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

NCT07400835

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Department of Obstetrics and Gynaecology, Aarhus University Hospital Aarhus N, Denmark
  • Department of Obstetrics and Gynaecology, Odense University Hospital Odense, Denmark
  • Department of Obstetrics and Gynaecology, Randers Regional Hospital Randers, Denmark
View Trial Details
Recruiting

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

NCT06239194

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +74 more
Locations
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Sylvester Comprehensive Cancer Center - University of Miami Health System Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Recruiting

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

NCT06023862

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +29 more
Locations
  • Monash Medical Centre Clayton, Clayton Rd., Australia
  • Calvary Mater Newcastle Waratah, Edith Saint, Australia
  • Peter MacCallum Cancer Centre Melbourne, Grattan Saint, Australia
  • University of Hong Kong Hong Kong, Pok Fu Ram
View all 27 locations
View Trial Details
Recruiting

Uterine Manipulator Versus no Uterine Manipulator in Endometrial Cancer Trial

NCT05687084

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • UOC Ostetricia e Ginecologia, Azienda Ospedaliera Santa Croce e Carle Cuneo, Italy
  • UOC Ostetricia e Ginecologia, Arcispedale Santa Maria Nuova Reggio Emilia, Italy
  • AOUI Verona - University of Verona - Department of Obstetrics and Gynecology Verona, Italy
View Trial Details
Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT04851119

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +90 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 21 locations
View Trial Details

Related conditions